Clinical Trial Update: A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder

View source ↗

Summary

The document notes the completion of a clinical trial evaluating quetiapine extended-release tablets for depressive symptoms in patients with bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Quetiapine extended-release tablets (quetiapine extended-release)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Depression, Bipolar Disorder | Status: COMPLETED